|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 06/16/06 | Allergan : Obama's inversion curbs kill Pfizer's $160 billion Allergan deal | RE |
| 31/16/31 | Argus Media close to stake sale, Temasek among bidders - sources | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Eric Boyer
IRC | Investor Relations Contact | - | 03/02/2014 |
Carlos Pascual
PRN | Corporate Officer/Principal | - | 12/01/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel H. Yergin
BRD | Director/Board Member | 79 | 26/11/2013 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.80% | +2.33% | -20.95% | +11.83% | 13TCr | |
| -0.93% | -1.19% | -41.87% | -18.25% | 4.51TCr | |
| +0.12% | +0.10% | -0.98% | +6.33% | 4.1TCr | |
| -0.55% | -0.42% | -22.74% | -4.30% | 2.25TCr | |
| -0.66% | -2.24% | -37.89% | -37.55% | 1.81TCr | |
| -0.65% | +1.28% | -5.01% | +6.17% | 1.63TCr | |
| -0.43% | -1.36% | +2.86% | +58.24% | 1.63TCr | |
| -0.65% | -1.06% | -22.39% | -31.26% | 1.05TCr | |
| +0.07% | -16.39% | +11.95% | +39.25% | 341.61Cr | |
| Average | -0.30% | +2.14% | -15.22% | +3.38% | 3.34TCr | |
| Weighted average by Cap. | +0.08% | +3.80% | -20.05% | +3.40% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
